Letter by Spiering et al Regarding Article, "Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial"

Publication date

2021-11-30

Authors

Spiering, WilkoORCID 0000-0002-2493-6407
Mali, WPTMISNI 0000000392849126
de Jong, Pim AORCID 0000-0003-4840-6854ISNI 0000000395539334

Editors

Advisors

Supervisors

Document Type

Letter

Collections

Open Access logo

License

taverne

Abstract

Keywords

Alendronate, Aortic Valve Stenosis/diagnostic imaging, Denosumab/adverse effects, Double-Blind Method, Humans, Taverne, Cardiology and Cardiovascular Medicine, Physiology (medical), Comment, Letter

Citation

Spiering, W, Mali, W P & de Jong, P A 2021, 'Letter by Spiering et al Regarding Article, "Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis : A Double-Blind Randomized Controlled Trial"', Circulation, vol. 144, no. 22, e334. https://doi.org/10.1161/CIRCULATIONAHA.121.055622